ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Kimiyuki Shibuya, 64, died on Feb. 17 in Tokyo.
“Dr. Shibuya established the manufacturing production process of our two pharmaceuticals, ripasudil for the treatment of glaucoma and pemafibrate, an antihyperlipidemic drug. He discovered the selective ACAT-1 inhibitor K-604, an antiarteriosclerotic agent.”—Tadaaki Ohgiya, friend and colleague
Most recent title: Laboratory manager, Kowa
Education: BS, chemistry, 1979; MS, chemistry, 1981; and PhD, chemistry, 1996, Tohoku University
Survivors: Sister, Kayoko Shibuya
To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X